Understanding how certain proteins influence cell movement away from harmful substances
Elucidation of a Eukaryotic Chemorepulsion Mechanism
This study is looking at how certain cells, like those involved in lung issues, move away from harmful substances, focusing on a protein called AprA, and it could help us understand and manage conditions like acute respiratory distress syndrome (ARDS).
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-11014339 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which eukaryotic cells move away from chemorepellents, specifically focusing on a protein called AprA. By using a model organism, Dictyostelium, the researchers aim to uncover the biochemical and genetic pathways involved in this process. The study explores how these pathways relate to human conditions, particularly acute respiratory distress syndrome (ARDS), where harmful neutrophils damage lung tissue. The findings could lead to new insights into controlling cell movement in inflammatory diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from acute respiratory distress syndrome or related inflammatory lung conditions.
Not a fit: Patients with non-respiratory conditions or those not affected by acute respiratory distress syndrome may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel treatments for acute respiratory distress syndrome, potentially reducing lung damage and improving patient outcomes.
How similar studies have performed: Other research has shown promising results in understanding cell movement mechanisms, but this specific approach focusing on AprA and its relation to ARDS is relatively novel.
Where this research is happening
College Station, United States
- Texas A&m University — College Station, United States (Active)
Researchers
- Principal investigator: Gomer, Richard H — Texas A&m University
- Study coordinator: Gomer, Richard H
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.